Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Methodology of phase II study].

M Ogawa

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |March 1, 1984
    PubMed
    Summary

    This review outlines Phase II clinical trial methodology for evaluating new antitumor agents. It details patient eligibility, tumor types, prognostic factors, efficacy measures, and response assessment criteria for these cancer drug studies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Present status and clinical therapy of pancreatic diseases].

    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·1992
    Same author

    Reptilian viruses: adenovirus-like agent isolated from royal python (Python regius).

    Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B·1992
    Same author

    Specific stimulation by estradiol of tissue-type plasminogen activator production in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1992
    Same author

    Magnocellular neurosecretory neurons with ferritin-like immunoreactivity in the hypothalamic supraoptic and paraventricular nuclei of the rat.

    Brain research·1992
    Same author

    Changes in IL-6, IL-8, C-reactive protein and pancreatic secretory trypsin inhibitor after transcatheter arterial chemo-embolization therapy for hepato-cellular carcinoma.

    Cytokine·1992
    Same author

    Light microscopic immunohistochemical analysis of the distribution of group II phospholipase A2 in human digestive organs.

    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·1992

    Area of Science:

    • Oncology
    • Clinical Pharmacology

    Context:

    • Phase II trials are crucial for assessing the efficacy and safety of novel therapeutic agents.
    • Understanding the methodology is key to interpreting trial results accurately.

    Purpose:

    • To describe the methodological framework for Phase II clinical trials investigating new antitumor agents.
    • To outline key components including patient selection, tumor characteristics, and response evaluation.

    Summary:

    • Details the essential elements of Phase II trial design for anticancer drugs.
    • Covers patient eligibility, identification of target (signal) tumors, and prognostic indicators.
    • Explains criteria for assessing treatment efficacy and patient response.

    Impact:

    • Provides a standardized approach for conducting and evaluating early-phase oncology trials.
    • Facilitates consistent assessment of new anticancer therapies, aiding drug development.
    • Enhances the understanding of factors influencing treatment outcomes in clinical research.

    Related Experiment Videos